EICHOR
● Completed
Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis · Sponsor: Alfasigma S.p.A.
About this study
The primary objective of this study is to evaluate the long-term safety and tolerability of filgotinib in participants who have completed one of the parent studies of filgotinib in rheumatoid arthritis (RA).
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (345)
| Rheumatology Associates of North Alabama, PC | Huntsville, Alabama, United States | — |
| Arthrocare, Arthritis Care & Research PC | Gilbert, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Associates, P.C. | Phoenix, Arizona, United States | — |
| Arizona Arthritis & Rheumatology Associates, P.C. | Tucson, Arizona, United States | — |
| Medvin Clinical Research | Covina, California, United States | — |
| C.V. Mehta M.D. Medical Corporation | Hemet, California, United States | — |
| University of California San Diego (UCSD) - Perlman Ambulatory Clinic | La Jolla, California, United States | — |
| Keck Medicine of USC- Division of Rheumatology | Los Angeles, California, United States | — |
| Desert Medical Advances | Palm Desert, California, United States | — |
| Stanford University Hospitals and Clinics (Immunology & Rheumatology) | Palo Alto, California, United States | — |
| C.V. Mehta Medical Corporation | Riverside, California, United States | — |
| Inland Rheumatology Clinical Trials, Inc. | Upland, California, United States | — |
+ 333 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.